GLPG Galapagos NV

track record → $29.28 +0.00 (+0.0%)
Get emailed when GLPG changes direction
Mkt Cap $2B P/E 5.1 fwd -18.3 52wk $24.31 - $37.78 Earnings 2026-05-06
Factor Model (net +1.5)

Factor Model

net +1.5
Est. Revisions
+0.0
Insider Activity
+0.0
Momentum
+0.0
Analyst Rev.
+1.0
Narrative Gap
+0.0

Analysis pending — waiting for first signal cycle.

Evidence

17d ago Galapagos NV (GLPG) Signs Agreement with Gilead on Ouro Medicines Assets yahoo-finance
24d ago Gilead to Acquire Ouro Medicines in $2.18B Deal, Expand Inflammation Pipeline yahoo-finance
Fundamentals & Data ▾
Galapagos NV Healthcare · Biotechnology
Mkt Cap
$2B
P/E
5.1 fwd -18.3
Beta
0.15
52w Range
$24.31 - $37.78
Short Interest
1.1M 2.71%
Days to Cover
5.9 +38%
Technicals downtrend
from 52w Hi
0.0%
1w return
+2.5%
EPS Estimate
$-0.97 +0.5% 30d 1up / 0dn
Est. Dispersion
27% 2 analysts
Analyst Target
$29 $29 - $29
Options P/C
2.73
Fund Convergence
strong Renaissance, Citadel, Two Sigma
Financials
Revenue
$901M +1093% YoY
FCF
$-49M
Gross Margin
100%
Op Margin
84%
Momentum: accelerating
Top Holders
Renaissance $10M
Citadel $4M
Two Sigma
2 signals · latest 17d ago

Get alerted when GLPG changes direction

We'll email you when our AI detects a shift — reversals, insider clusters, filing red flags.

All stocks → Our calls → How it works →